News 2023/08/15 SAEKI Robotics secures investment of 2.3 million US dollars SAEKI Robotics has secured investment of 2.3 million US dollars as part of a seed funding round. The fresh capital will be put towards building a...
News 2023/06/02 Abiogen Pharma acquires majority stake in EffRx Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abioge...
Spotlight 2023/06/15 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Medienmitteilungen 2022/03/08 Switzerland Global Enterprise und Schweiz Tourismus holen innovative Firmen in die Schweiz Die Schweiz ist als Innovationsstandort prädestiniert für die Entwicklung neuer Geschäftsmodelle mit Zukunftstechnologien. Eine wichtige Rolle sp...
Communiqués de Presse 2022/04/06 Switzerland Global Enterprise et Suisse Tourisme invitent des Enterprises d'avant-garde à s'établir en Suisse Berceau de quantité d’innovations, la Suisse est propice au développement de nouveaux modèles d’affaires impliquant les technologies d’avenir. L’...
Press Release 2022/03/08 Switzerland Global Enterprise and Switzerland Tourism attract innovative companies to Switzerland As a location for innovation, Switzerland is predestined for the development of new business models with future technologies. The settlement of i...
Comunicati Stampa 2022/03/10 Switzerland Global Enterprise e Svizzera Turismo invitano aziende innovative in Svizzera La Svizzera, nel suo ruolo di piazza d’innovazione, è ideale per lo sviluppo di nuovi modelli di business con tecnologie del futuro. Un ruolo imp...
News 2021/11/17 Inflamalps takes part in a significant biopharmaceutical research project Biopharmaceutical company Inflamalps has just entered a major Innosuisse project, which aims to discover at least one new class of antimicrobial ...